CGN Advisors LLC cut its stake in KLA Co. (NASDAQ:KLAC – Free Report) by 1.9% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,600 shares of the semiconductor company’s stock after selling 109 shares during the period. CGN Advisors […]
CGN Advisors LLC cut its holdings in Dimensional US Core Equity Market ETF (NYSEARCA:DFAU – Free Report) by 8.7% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 151,695 shares of the company’s stock after selling 14,507 shares during the quarter. CGN […]
CGN Advisors LLC raised its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 15.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 31,585 shares of the biopharmaceutical company’s stock after buying an additional 4,187 shares during […]
CGN Advisors LLC lessened its stake in shares of Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO – Free Report) by 0.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 92,929 shares of the exchange traded fund’s stock after selling 717 shares during […]
CGN Advisors LLC boosted its holdings in Mastercard Incorporated (NYSE:MA – Free Report) by 6.2% during the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 6,606 shares of the credit services provider’s stock after buying an additional 386 shares during the period. CGN Advisors LLC’s holdings in Mastercard were […]